articleTop 1% cited
Gadodiamide-Associated Nephrogenic Systemic Fibrosis: Why Radiologists Should Be Concerned
American Journal of Roentgenology · 2007 · Vol. 188(2) · pp. 586–592
Dale R. Broome✉(Loma Linda University Medical Center)Mark S. Girguis(Loma Linda University Medical Center)Pedro Baron(Loma Linda University Medical Center)Alfred Cottrell(Loma Linda University Medical Center)Ingrid Kjellin(Loma Linda University Medical Center)Gerald A. Kirk(Loma Linda University Medical Center)
Abstract
Development of NSF was strongly associated with gadodiamide administration in the setting of either acute hepatorenal syndrome or dialysis-dependent chronic renal insufficiency.
Lanthanide and Transition Metal ComplexesMedical Imaging and Pathology StudiesAdvanced MRI Techniques and ApplicationsGadodiamideMedicineNephrogenic systemic fibrosisDialysisKidney diseaseRenal replacement therapyMagnetic resonance imagingRadiologySurgeryInternal medicine
MeSH terms
AdultCaliforniaFemaleFibrosisRenal DialysisHumansMagnetic Resonance ImagingMaleMiddle AgedRetrospective StudiesRisk FactorsSkin DiseasesComorbidityCausalityIncidence
Citations
605
FWCI
65.66
field-weighted impact
References
149
Percentile
100%
vs. same field & year
Citations per year
Cited by
Nanoscale Metal–Organic Frameworks for Biomedical Imaging and Drug Delivery
Accounts of Chemical Research · 2011 · 2,071 citations
ACR Guidance Document for Safe MR Practices: 2007
American Journal of Roentgenology · 2007 · 782 citations
References
Gadolinium – a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis?
Nephrology Dialysis Transplantation · 2006 · 1,830 citations
Nephrogenic Systemic Fibrosis
Journal of the American Society of Nephrology · 2006 · 1,378 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.